Global Intraoperative Neuromonitoring Market Size, Share & Trends Analysis Report By Source Type, By End User, By Products & Services, By Application, By Modality, By Regional Outlook and Forecast, 2023 - 2030
The Global Intraoperative Neuromonitoring Market size is expected to reach $7 billion by 2030, rising at a market growth of 6.0% CAGR during the forecast period.
Orthopedic surgeons frequently perform spinal surgeries, including spinal fusions, laminectomies, and discectomies. In these procedures, this neuromonitoring is vital for assessing the integrity of neural structures such as the spinal cord and nerve roots, ensuring their preservation during instrumentation and fusion processes. Consequently, the orthopedic surgery segment would acquire nearly 20% of the total market share by 2030. Orthopedic surgeries related to joint replacements, such as hip and knee replacements, may involve monitoring peripheral nerves to avoid injury during implantation. IONM provides valuable feedback to surgeons, helping prevent nerve damage and postoperative complications.
The overall growth in surgical procedures, including neurosurgery, orthopedics, and cardiovascular surgeries, significantly drives the demand for this neuromonitoring. As surgical volumes rise globally, so does the need for techniques that ensure the safety of critical neural structures. The adoption of minimally invasive surgical techniques is expanding across various medical specialties. In minimally invasive procedures, where direct visualization may be limited, this neuromonitoring provides real-time feedback to surgeons, contributing to the growth of IONM. Hence, the market is expanding significantly due to the increasing surgical procedures. Additionally, advancements in electrode technology have led to the development of high-resolution electrodes capable of capturing detailed neural signals. These electrodes provide clearer and more precise information about the functional integrity of neural structures during surgery. Surgeons and healthcare professionals can utilize these devices in various surgical settings, including ambulatory surgical centers and outpatient facilities. Advanced signal processing algorithms enhance the accuracy of data interpretation. Therefore, technological advancements in neuromonitoring technologies have been a pivotal factor in driving the growth of the market.
However, Regulatory bodies often impose stringent requirements for medical devices and procedures, including IONM systems. Manufacturers may find it difficult and expensive to meet these standards, which may delay the introduction of innovative technology. Smaller companies with innovative IONM solutions may face challenges navigating complex regulatory processes. This can create barriers to entry into the market for smaller enterprises, limiting competition and potentially hindering technological advancements. Hence, regulatory compliance and standardization are a significant challenge that hampers the growth of market.
Moreover, the availability of medical equipment, particularly IONM devices and accessories, was impacted by disruptions in the global supply chain. This led to delays in the procurement and maintenance of IONM systems. Hospitals and healthcare facilities faced the challenge of reallocating resources to manage the surge in COVID-19 cases. This resulted in a change in focus, emphasizing critical and emergency surgeries, which may affect the use of IONM in elective or non-urgent procedures. Thus, the COVID-19 pandemic had a moderate effect on the market.
By Source Type Analysis
Based on source type, the market is bifurcated into insourced monitoring and outsourced monitoring. The outsourced monitoring segment acquired a substantial revenue share in the market in 2022. Outsourced monitoring offers scalability and flexibility in adjusting monitoring services based on demand. Healthcare institutions can scale up or down their neuromonitoring services as needed without the constraints of maintaining a fixed in-house team. Outsourced monitoring services offer rapid deployment and on-demand availability. This can be particularly beneficial for healthcare facilities requiring immediate access to neuromonitoring services without delays associated with internal setup.
By End User Analysis
Based on end user, the market is segmented into hospitals and ambulatory surgical centers (ASCs). The ambulatory surgical centers (ASCs) segment covered a considerable revenue share in the market in 2022. ASCs have experienced a steady rise in the volume of surgical procedures performed on an outpatient basis. As the demand for ambulatory surgery increases, so does the need for this neuromonitoring to enhance patient safety and surgical precision. ASCs prioritize patient-centric care, and integrating this neuromonitoring aligns with this focus. ASCs can provide advanced care alternatives in a patient-friendly environment by improving patient safety and lowering the risk of neurological problems. As ASCs increasingly adopt this neuromonitoring, surgeons and medical staff become more familiar with the technology. This familiarity fosters a positive environment for integrating IONM into a broader range of surgical procedures at ASCs.
By Products & Services Analysis
By products & services, the market is categorized into systems, accessories, and services. The accessories segment covered a considerable revenue share in the market in 2022. Specialized electrodes and sensors are crucial accessories in IONM. These components are directly applied to the patient to capture neural signals accurately. Advancements in electrode materials and designs contribute to improved signal quality and reduced interference, enhancing the overall reliability of IONM. Accessories that aid in precisely placing electrodes are essential for optimizing the monitoring process. These tools ensure accurate positioning, critical for obtaining reliable and meaningful neural data during surgery.
By Application Analysis
On the basis of application, the market is divided into spinal surgery, neurosurgery, orthopedic surgery, ENT surgery, vascular surgery, and others. The neurosurgery segment garnered a significant revenue share in the market in 2022. Neurosurgery involves highly intricate procedures within the brain and spinal cord. The complexity of these interventions necessitates precise monitoring of neural structures to avoid damage and ensure optimal outcomes. IONM provides real-time feedback to surgeons during neurosurgical procedures. Advances in neurosurgical techniques, including minimally invasive procedures and image-guided surgeries, are complemented by the integration of this neuromonitoring. The combined use of these technologies enhances the precision and safety of neurosurgical interventions.
By Modality Analysis
By modality, the market is classified into motor evoked potentials (MEPs), somatosensory evoked potentials (SSEPs), electroencephalography (EEG), electromyography (EMG), brainstem auditory evoked potentials (BAEPs), and visual evoked potentials (VEPs). The electroencephalography (EEG) segment recorded a remarkable revenue share in the market in 2022. EEG is a valuable tool for monitoring brain function in real time. During surgeries, especially those involving the brain or procedures that may impact cerebral blood flow, EEG provides continuous feedback on the brain's electrical activity. EEG monitoring is extensively used in neurosurgical procedures, including brain tumor resections and epilepsy surgeries. Monitoring the EEG helps surgeons navigate critical brain regions and identify abnormal patterns, contributing to the success of these delicate procedures. EEG plays a crucial role in surgeries related to epilepsy, where precise localization of the epileptic focus is essential. Continuous EEG monitoring assists in identifying seizure activity and guides respective surgery or other interventions.
By Regional Analysis
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. North America boasts an advanced healthcare infrastructure with well-established medical facilities, research centers, and hospitals. The North American region witnesses a significant number of spinal surgeries, including procedures for degenerative spine conditions, herniated discs, and spinal fusions. The region experiences many orthopedic procedures, including joint replacements and complex orthopedic surgeries. The aging population in North America contributes to a higher demand for surgical interventions, particularly in neurosurgery and orthopedics.
List of Key Companies Profiled
Nihon Kohden Corporation
inomed Medizintechnik GmbH
Medtronic PLC
SpecialtyCare, Inc. (Morgan Stanley)
NeuroStyle Pte. Ltd.
Computational Diagnostics, Inc.
Accurate Neuromonitoring, LLC (Housatonic Partners)
Intranerve Neuroscience Holdings, Llc
Natus Medical Incorporated (Archimed SAS)
Globus Medical, Inc.
Global Intraoperative Neuromonitoring Market Report Segmentation
By Source Type
Insourced Monitoring
Outsourced Monitoring
By End User
Hospitals
Ambulatory Surgical Centers (ASCs)
By Products & Services
Services
Systems
Accessories
By Application
Spinal Surgery
Neurosurgery
Orthopedic Surgery
ENT Surgery
Vascular Surgery
Others
By Modality
Electromyography (EMG)
Electroencephalography (EEG)
Motor Evoked Potentials (MEPs)
Somatosensory Evoked Potentials (SSEPs)
Visual Evoked Potentials (VEPs)
Brainstem Auditory Evoked Potentials (BAEPs)
By Geography
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Intraoperative Neuromonitoring Market, by Source Type
1.4.2 Global Intraoperative Neuromonitoring Market, by End User
1.4.3 Global Intraoperative Neuromonitoring Market, by Products & Services
1.4.4 Global Intraoperative Neuromonitoring Market, by Application
1.4.5 Global Intraoperative Neuromonitoring Market, by Modality
1.4.6 Global Intraoperative Neuromonitoring Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Global Intraoperative Neuromonitoring Market by Source Type
4.1 Global Insourced Monitoring Market by Region
4.2 Global Outsourced Monitoring Market by Region
Chapter 5. Global Intraoperative Neuromonitoring Market by End User
5.1 Global Hospitals Market by Region
5.2 Global Ambulatory Surgical Centers (ASCs) Market by Region
Chapter 6. Global Intraoperative Neuromonitoring Market by Products & Services
6.1 Global Services Market by Region
6.2 Global Systems Market by Region
6.3 Global Accessories Market by Region
Chapter 7. Global Intraoperative Neuromonitoring Market by Application
7.1 Global Spinal Surgery Market by Region
7.2 Global Neurosurgery Market by Region
7.3 Global Orthopedic Surgery Market by Region
7.4 Global ENT Surgery Market by Region
7.5 Global Vascular Surgery Market by Region
7.6 Global Others Market by Region
Chapter 8. Global Intraoperative Neuromonitoring Market by Modality
8.1 Global Electromyography (EMG) Market by Region
8.2 Global Electroencephalography (EEG) Market by Region
8.3 Global Motor Evoked Potentials (MEPs) Market by Region
8.4 Global Somatosensory Evoked Potentials (SSEPs) Market by Region
8.5 Global Visual Evoked Potentials (VEPs) Market by Region
8.6 Global Brainstem Auditory Evoked Potentials (BAEPs) Market by Region
Chapter 9. Global Intraoperative Neuromonitoring Market by Region
9.1 North America Intraoperative Neuromonitoring Market
9.1.1 North America Intraoperative Neuromonitoring Market by Source Type
9.1.1.1 North America Insourced Monitoring Market by Region
9.1.1.2 North America Outsourced Monitoring Market by Region
9.1.2 North America Intraoperative Neuromonitoring Market by End User
9.1.2.1 North America Hospitals Market by Region
9.1.2.2 North America Ambulatory Surgical Centers (ASCs) Market by Region
9.1.3 North America Intraoperative Neuromonitoring Market by Products & Services
9.1.3.1 North America Services Market by Country
9.1.3.2 North America Systems Market by Country
9.1.3.3 North America Accessories Market by Country
9.1.4 North America Intraoperative Neuromonitoring Market by Application
9.1.4.1 North America Spinal Surgery Market by Country
9.1.4.2 North America Neurosurgery Market by Country
9.1.4.3 North America Orthopedic Surgery Market by Country
9.1.4.4 North America ENT Surgery Market by Country
9.1.4.5 North America Vascular Surgery Market by Country
9.1.4.6 North America Others Market by Country
9.1.5 North America Intraoperative Neuromonitoring Market by Modality
9.1.5.1 North America Electromyography (EMG) Market by Country
9.1.5.2 North America Electroencephalography (EEG) Market by Country
9.1.5.3 North America Motor Evoked Potentials (MEPs) Market by Country
9.1.5.4 North America Somatosensory Evoked Potentials (SSEPs) Market by Country
9.1.5.5 North America Visual Evoked Potentials (VEPs) Market by Country
9.1.5.6 North America Brainstem Auditory Evoked Potentials (BAEPs) Market by Country
9.1.6 North America Intraoperative Neuromonitoring Market by Country
9.1.6.1 US Intraoperative Neuromonitoring Market
9.1.6.1.1 US Intraoperative Neuromonitoring Market by Source Type
9.1.6.1.2 US Intraoperative Neuromonitoring Market by End User
9.1.6.1.3 US Intraoperative Neuromonitoring Market by Products & Services
9.1.6.1.4 US Intraoperative Neuromonitoring Market by Application
9.1.6.1.5 US Intraoperative Neuromonitoring Market by Modality